Charles River rises on 2026 forecast update, long-term targets
CRL•Charles River expects 2026 organic revenue growth and adjusted EPS at the upper ends of its previous forecasts: 0% to 1% and $11.15 to $11.45, respectively. It targets 5% to 7% annual organic revenue growth and low-double-digit adjusted EPS growth from 2027 through 2030.
1. Forecasts and targets
Charles River expects 2026 organic revenue growth and adjusted EPS at the upper ends of its previous forecasts, citing continued favorable demand from biotech and pharmaceutical clients. The company targets annual organic revenue growth of 5% to 7% and low-double-digit adjusted EPS growth from 2027 through 2030, with adjusted operating margin reaching about 24% by 2030, compared with a 2026 forecast of 21% to 21.3%. It plans to save more than $300 million from 2027 through 2030 by simplifying operations and increasing the use of automation and digital tools.
